357 related articles for article (PubMed ID: 33344513)
1. Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology.
Brown SA; Zaharova S; Mason P; Thompson J; Thapa B; Ishizawar D; Wilkes E; Ahmed G; Rubenstein J; Sanchez J; Joyce D; Kalyanaraman B; Widlansky M
Front Cardiovasc Med; 2020; 7():568720. PubMed ID: 33344513
[TBL] [Abstract][Full Text] [Related]
2. Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story.
Bisceglia I; Canale ML; Gallucci G; Turazza FM; Lestuzzi C; Parrini I; Russo G; Maurea N; Quagliariello V; Oliva S; Di Fusco SA; Lucà F; Tarantini L; Trambaiolo P; Moreo A; Geraci G; Gabrielli D; Gulizia MM; Oliva F; Colivicchi F
Front Cardiovasc Med; 2022; 9():821193. PubMed ID: 35155636
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Cardio-Oncology Care During the COVID-19 Pandemic.
Abraham S; Manohar SA; Patel R; Saji AM; Dani SS; Ganatra S
Curr Treat Options Cardiovasc Med; 2022; 24(8):137-153. PubMed ID: 36090762
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
5. Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.
Gressens SB; Leftheriotis G; Dussaule JC; Flamant M; Levy BI; Vidal-Petiot E
Front Physiol; 2021; 12():624052. PubMed ID: 33692701
[TBL] [Abstract][Full Text] [Related]
6. The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic.
Kwan JM; Henry ML; Christophers B; Tamirisa K; Thamman R; Sadler D; Aggarwal NR; Cheng R; Parwani P; Dent S; Ismail-Khan R; Fradley MG; Brown SA
Curr Oncol Rep; 2021 Jul; 23(8):99. PubMed ID: 34259950
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities.
Ky B; Mann DL
JACC Basic Transl Sci; 2020 May; 5(5):501-517. PubMed ID: 32309679
[TBL] [Abstract][Full Text] [Related]
8. Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019.
Bae S; Kim JH; Kim YJ; Lim JS; Yun SC; Kim YH; Lee SO; Kim SH
Open Forum Infect Dis; 2020 Nov; 7(11):ofaa519. PubMed ID: 33235892
[TBL] [Abstract][Full Text] [Related]
9. Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients.
Farid Fahmy S; El Derany MO; Khorshid H; Saleh A; El-Demerdash E
BMC Pharmacol Toxicol; 2023 Apr; 24(1):24. PubMed ID: 37060024
[TBL] [Abstract][Full Text] [Related]
10. The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.
Zhang J; Wang M; Ding W; Wan J
Life Sci; 2020 Sep; 257():118142. PubMed ID: 32712300
[TBL] [Abstract][Full Text] [Related]
11. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
[TBL] [Abstract][Full Text] [Related]
12. Relation Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Severity.
Alhaddad MJ; Almulaify MS; Alshabib AA; Alwesaibi AA; Alkhameys MA; Alsenan ZK; Alsheef HJ; Alsaghirat MA; Almomtan MS; Alshakhs MN
Cureus; 2022 Mar; 14(3):e22903. PubMed ID: 35399441
[TBL] [Abstract][Full Text] [Related]
13. A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic.
Brown SA; Patel S; Rayan D; Zaharova S; Lin M; Nafee T; Sunkara B; Maddula R; MacLeod J; Doshi K; Meskin J; Marks D; Saucedo J
Cardiooncology; 2021 Jan; 7(1):2. PubMed ID: 33441188
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and its management in COVID-19 patients: The assorted view.
Batiha GE; Gari A; Elshony N; Shaheen HM; Abubakar MB; Adeyemi SB; Al-Kuraishy HM
Int J Cardiol Cardiovasc Risk Prev; 2021 Dec; 11():200121. PubMed ID: 34806090
[TBL] [Abstract][Full Text] [Related]
15. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.
Pirola CJ; Sookoian S
J Infect; 2020 Aug; 81(2):276-281. PubMed ID: 32474043
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
Dworakowska D; Grossman AB
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
[TBL] [Abstract][Full Text] [Related]
17. Is diabetes mellitus a wrongdoer to COVID-19 severity?
Sarkar S; Das D; Borsingh Wann S; Kalita J; Manna P
Diabetes Res Clin Pract; 2021 Aug; 178():108936. PubMed ID: 34217771
[TBL] [Abstract][Full Text] [Related]
18. COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice.
Katsi V; Pavlidis G; Charalambous G; Tousoulis D; Toutouzas K
Curr Hypertens Rev; 2022; 18(1):3-10. PubMed ID: 33475077
[TBL] [Abstract][Full Text] [Related]
19. Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19.
Sinha S; Sehgal A; Sehgal R
Drug Discov Ther; 2020; 14(4):161-170. PubMed ID: 32908071
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system inhibition in COVID-19 patients.
de Vries AAF
Neth Heart J; 2020 Jul; 28(7-8):396-405. PubMed ID: 32514935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
